NUTRIBURST LTD

Company number 12117119 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Executive Summary
Nutriburst Ltd is a UK-based direct-to-consumer and online retailer of multivitamin supplements that has scaled turnover by approximately 60% to £2.25m in FY2025. However, rapid top-line growth has been accompanied by severe gross-margin compression and a swing to a £245k operating loss, leaving the company dependent on parent-company funding and a shareholder personal guarantee to meet its obligations. The business is at a critical inflection point where margin recovery and working-capital discipline are prerequisites for sustainable scale.

Strategic Assets
- Revenue momentum: Turnover growth from £1.4m to £2.25m validates product-market fit in the UK supplements market and demonstrates the ability to acquire customers at scale.
- Omnichannel eligibility: SIC classifications span both specialised store retail and internet/mail-order sales, providing a foundation for expansion beyond the current online-first model.
- Parent-company backing: Triumph Holding KFT provides a £200k convertible loan and has committed, per the accounts, to at least 12 months of financial support, underpinning the going-concern position.
- Inventory and supply-chain position: £643k of stock, including goods in transit, signals established supplier relationships and the capacity to fulfil demand.
- Lean employment base: An average headcount of three limits fixed employment costs relative to revenue scale, though administrative expenses have risen sharply.

Growth Opportunities
- Margin restoration: Gross margin fell from roughly 65% to 39% in FY2025. Revisiting pricing, supplier terms, and product mix is the highest-value lever to recover contribution without requiring additional customers.
- Channel and geographic expansion: Moving beyond direct online sales into specialised retail (SIC 47290) and EU/export markets would diversify revenue and reduce reliance on a single acquisition channel.
- Product adjacency: Extending the multivitamin range into targeted nutrition, sports wellness, or condition-specific SKUs can increase basket size and customer lifetime value.
- Working-capital release: Cash fell from £238k to £51k. Tightening stock-in-transit management, debtor collection, and creditor payment terms would improve liquidity and reduce dependence on external funding.
- Group synergies: Leveraging the parent company’s resources for procurement, logistics, or shared services could help bring administrative expenses—which rose 58% in FY2025—under control.

Strategic Risks
- Profitability erosion: The company swung from a £325k profit to a £245k loss despite higher revenue, indicating that current scale is value-destructive unless unit economics are repaired.
- Liquidity and solvency pressure: Cash of £51k covers only a fraction of £973k of short-term creditors, including a £565k bank loan secured by a fixed charge and a personal guarantee from a person with significant control. Withdrawal of parent support would threaten the going-concern assumption stated in the accounts.
- Working-capital intensity: High levels of stock (£643k) and debtors (£421k) relative to cash create cash-cycle risk, particularly if sales growth slows or inventory obsolescence rises.
- Ownership and governance concentration: Two persons with significant control each hold 25–50% of shares and voting rights, and the board is small. The accounts state that a loan from a former director was repaid during the year, highlighting related-party funding reliance.
- Competitive and regulatory exposure: The online supplements market is crowded and low-barrier to entry, while product claims and labelling remain subject to UK and EU food-safety regulation.

Perspective: Strategic Business Consultant · Model: nvidia/nemotron-3.5-super-vl:free · Generated 14 November 2026